1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-8 of 8 (Search time: 0.002 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancerDelea, T.; Karnon, J.; Smith, R.; Johnston, S.; Brandman, J.; Sung, J.; Goss, P.
2013A model-based economic evaluation of improved primary care management of patients with type 2 diabetes in AustraliaHajiali Afzali, H.; Gray, J.; Beilby, J.; Holton, C.; Karnon, J.
2012Applying risk adjusted cost-effectiveness (RAC-E) analysis to hospitals: estimating the costs and consequences of variation in clinical practiceKarnon, J.; Caffrey, O.; Pham, C.; Grieve, R.; Ben-Tovim, D.; Hakendorf, P.; Crotty, M.
2015Cost-value analysis and the SAVE: a work in progress, but an option for localised decision making?Karnon, J.; Partington, A.
2005Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UKKarnon, J.; Brennan, A.; Pandor, A.; Fowkes, G.; Lee, A.; Gray, D.; Coshall, C.; Nicholls, C.; Akehurst, R.
2012Evaluating the effects of variation in clinical practice: a risk adjusted cost-effectiveness (RAC-E) analysis of acute stroke servicesPham, C.; Karnon, J.; Caffrey, O.; Ben-Tovim, D.; Hakendorf, P.; Crotty, M.
2009Cost-effectiveness analysis of adjuvant therapy for operable breast cancer from a Chinese perspective: Doxorubicin plus Cyclophosphamide versus Docetaxel plus CyclophosphamideLiubao, P.; Xiaomin, W.; Chongqing, T.; Karnon, J.; Gannong, C.; Jianhe, L.; Wei, C.; Xia, L.; Junhua, C.
2013A risk adjusted cost-effectiveness analysis of alternative models of nurse involvement in obesity management in primary careKarnon, J.; Hajiali Afzali, H.; Gray, J.; Holton, C.; Banham, D.; Beilby, J.

Discover